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Abstract 
The utilization of isotopes of transition metals for the development of novel therapeutic or 
diagnostic compounds is limited by the fact that they must be stabilized by chelating systems in 
coordination complexes. Important roles in the targeting approach are played by the tricarbonyl 
complexes of Technetium(I) and Rhenium(I) because they can be readily conjugated to 
biomolecules to form stable probes. Additionally, 
67
Ga and 
68
Ga isotopes of gallium are considered 
an obvious alternative to 
99m
Tc
1111111
 for SPECT and PET applications.  
We have previously reported the characterization of the peptide CCK8 decorated with a bis-
histidine-based chelator (pHis2) labeled with 
99m
Tc-tricarbonyl.  
In order to study the molecular properties of the histidine-based chelator pHis2, we here present the 
characterization in solution of its complexes with the metals Re(I) and Ga(III) using potentiometry 
and NMR. We detail the solution equilibria reporting pHis2 acid-base behavior, the coordination 
properties of pHis2 toward fac[Re(H2O)3(CO)3]
+
 and Ga(III) and the atomic details of the formed 
complexes. Interestingly, two different metal coordination modes were found highlighting the 
plasticity of this bifunctional chelator.  
  
Introduction 
Radiolabeled peptides are useful compounds to be exploited for the diagnosis and therapy of a 
variety of human diseases characterized by overexpression of peptide cognate receptors. These 
molecules are usually composed by the targeting molecule (peptide moiety), a linker and a 
bifunctional ligand which binds to the radioactive metal. Several radiometals are being used in 
nuclear medicine such as 
99m
Tc/
188
Re which Tc(I)- or Re(I)-complexes [Tc(H2O)3(CO)3]
+
 
(abbreviated as TcCO) or [Re(H2O)3(CO)3]
+
 (abbreviated as ReCO) could be prepared through a 
mild synthetic procedure
2
. In these complexes the water molecules can be replaced by ligands to 
obtain d
6
 low spin complexes. Ligands replacing all water molecules can form very stable 
complexes, avoiding trans-chelation reactions, which may occur in vivo, and the generation of free 
metal. Between several ligands for Tc(CO)/Re(CO) that have been reported
3
, special interest 
assume chelator moieties based on histidine side-chain as the imidazole ring is a good ligand for 
Tc(I)/Re(I) because of the aromatic sp
2
 amine function. Several histidine–based chelating units have 
been reported so far. Earlier, it was shown that His positioned at the N-terminus of a peptide acts as 
convenient bidentate ligand
4
. To fully exploit the coordination properties of His as multidentate 
ligand, diverse His derivatives have been appended to the N-terminal peptide region
4-7
. To take 
advantage of the avidity phenomenon, modules with multiple histidines have been reported. His-tag 
appended to a protein of interest
8, 9
 or his-his dipeptide
10
 have been labeled respectively with TcCO 
and ReCO. Finally, tag composed of repetitive His-X dipeptides, such as HEHEHE-tag, have been 
described
11, 12
. We reported the in vitro and in vivo characterization of the peptide CCK8 decorated 
with a bis-histidine-based chelator (pHis2) and labeled with 
99m
Tc-tricarbonyl
13
. The compound 
showed a specific high affinity binding to CCK2R receptors in vivo and cellular internalization. In 
imaging experiments, while concentration of the compound in the CCK2R positive tumors could be 
appreciated, there was poor contrast between target and non-target areas mainly due to 
accumulation in kidney and liver
13
.  
In order to shed light on the coordination properties of the bifunctional ligand we characterize in 
solution the complex between the metal Re(I) and the histidine-based chelator pHis2. In particular, 
we analyze the chemistry in aqueous solution and the molecular properties of pHis2 complexed to 
ReCO using NMR and potentiometry. 
Furthermore, we also exploited the complexation of pHis2 with Ga(III), as isotopes of gallium, 
including 
67
Ga for SPECT and 
68
Ga for PET, are considered an obvious alternative to 
99m
Tc
1
. The 
coordination chemistry of Ga(III) cation is dominated by functional groups like carboxylate, 
phosphonate, hydroxamate and amine. Gallium is mainly complexed using linear or macrocyclic 
polydentate chelator possessing hard donor groups (for example DTPA, NOTA, DOTA, 
deferoxamine), but an imidazole-based chelator has been also reported
14
. To analyze the chemistry 
in aqueous solution of Ga(III) cation complexed with aromatic amine, Ga(III)-His and Ga(III)-
pHis2 complexes were characterized in aqueous solution by NMR and potentiometry. Interestingly, 
the Re(I) and Ga(III) metal ions show different binding mode to the pHis2 peptide. The structural 
and coordination differences have been determined revealing an unexpected molecular plasticity of 
the pHis2 unit. 
  
Experimental section 
Materials and methods 
All amino acids and coupling reagents (HOBT and HBTU) were acquired from Novabiochem 
(Laüfelfingen, Switzerland), N,Ndimethylformamide (DMF) from Lab-Scan (Dublin, Ireland), 
DIPEA and trifluoroacetic acid (TFA) from Romil (Cambridge, UK), acetic anhydride from 
Applied Biosystem. Dichloromethane, Piperidine, 1,2-ethandithiol (EDT) were obtained from Fluka 
(Steinheim, Germany), triisopropylsilane from Aldrich (Steinheim, Germany). Acetonitrile HPLC 
grade was from Riedel-de Haën (Schnelldorf, Germany). 
Dilute solutions of perchloric acid were prepared from Merck p.a. products and standardized 
potentiometrically (glass electrode) against tris(hydroxymethyl)amino methane (Aldrich) 
recrystallized from water twice and dried over conc. H2SO4 in vacuo. The acid concentration was 
checked by coulometry. The results agreed to within 0.1% or better. 
Sodium hydroxide solutions, CO2free, were obtained by centrifugation of 50% “oil” as described 
in an earlier publication
15
. To prevent air contact the tubes were closed with a suba seal rubber. An 
approximately known quantity of NaOH was withdrawn with syringe and, at once, transferred 
under nitrogen atmosphere, in a calibrated volumetric flask containing NaClO4 in the desired 
quantity, freshly boiled bidistilled water and soon brought to the mark. The accurate hydroxide 
concentration was determined by titration with HCl using methylred as a visual indicator. The 
analyses agreed to within 0.1%. 
Sodium perchlorate source was the Merck p.a. NaClO4H2O. Solutions 6 molal of the salt contain 
less than 10
5
 molal concentration of iron, silica, heavy metals chloride and sulphate ions. Stock 
solutions were analyzed gravimetrically by drying at 130 C. 
Gallium perchlorate, Ga(ClO4)36H2O, source was the Sigma Aldrich. 
Nitrogen gas was taken from commercial cylinders and was purified by passing it through 10% 
H2SO4, 10% NaOH water and the ionic medium. 
2
H2O (99.9% relative isotopic abundance) was purchased from Cambridge Isotope Laboratories. 
 
Synthesis of fac[Re(H2O)3(CO)3]
+
  
fac-[Re(H2O)3(CO)3]
+
 was prepared starting from Rhenium(I) pentacarbonyl  chloride (Aldrich) as 
already reported 
16,17
. 
 
Synthesis of the peptide chelator and its analogues 
pHis2 (H-Lys(His)-Ala-Lys(His)-NH2), Ac-pHis2 (Ac-Lys(His)-Ala-Lys(His)-NH2) and Ac3-
pHis2 (Ac-Lys(Ac

-His)-Ala-Lys(Ac-His)-NH2) were synthesized on solid phase by standard 
Fmoc chemistry on the Rink Amide PEG-MBHA resin (0.54 mmol/g, Iris Biotech) performing the 
deprotection steps by incubation with 30% piperidine in dimethylformamide (DMF) (2 x 5 min), 
coupling reactions with a 10-fold excess of Fmoc-protected amino acid (Iris Biotech), 10 eq of 
COMU and 20 eq of N,N-Diisopropylethylamine (DIPEA) (1 x 30 min) and washes with DMF. The 
lysine residues were introduced as N-α-Fmoc-N-ε-4-methyltrityl-L-lysine (Iris Biotech). After the 
assembling of the linear chain, N-ε-4-methyltrityl-L-lysine residues were deprotected by treatment 
with a solution of trifluoroacetic acid (TFA, Sigma-Aldrich), triisopropylsilane (TIS, Sigma-
Aldrich) and dichloromethane (DCM, Sigma-Aldrich) 1/5/94 v/v/v (1 x 1 min with the solution of 
TFA/TIS/DCM and 3 x 1 min with DCM, repeated 10 times). Then, Fmoc-His(trt)-OH was coupled 
on the side-chain of the Lys residues, using 20 eq of the Fmoc-protected amino acid, 20 eq of 
COMU and 40 eq of DIPEA (30 min). Ac-pHis2 was selectively acetylated on N-terminal -amino 
group of Lys after linear peptide assembly deprotecting the Fmoc group and using a solution of 2 M 
acetic anhydride, 0.55 M DIPEA, 0.06 M HOBt in NMP (5 min). Peptide Ac3-pHis2 was acetylated 
on N-terminal -amino groups after full Fmoc deprotection by incubation with 30% piperidine in 
DMF (2 x 5 min) and acetylation by treatment with a solution of 2 M acetic anhydride, 0.55 M 
DIPEA, 0.06 M HOBt in NMP (10 min).  
Peptides were cleaved off the resin by incubation with a solution of TFA/TIS/H2O (95/2.5/2.5) (3 h, 
at room temperature, under stirring) and precipitated in cold diethyl ether. Peptides were finally 
purified by RP-HPLC on an Axia Synergi 4µ MAX-RP, 80 Å, 50 x 21.2 mm column applying a 
gradient of CH3CN (0.1% TFA) in H2O (0.1% TFA) from 1% to 40% in 20 min. Analytical 
characterization by RP-HPLC of peptides was carried out using a column Jupiter Proteo 150 x 4.6 
mm, 90 Å, 4 µ (Phenomenex), applying a gradient of CH3CN (0.1% TFA) in H2O (0.1% TFA) from 
1% to 40% in 20 min (Figure S1). The purity of all peptides was greater than 95% and was 
estimated by RP-HPLC evaluating the area of the chromatographic peaks revealed at 210 nm. 
Peptides were identified by ESI ToF mass analysis  
pHis2: MWth= 618.36 Da, MWexp= 618.37 Da 
Ac-pHis2: MWth= 660.37 Da, MWexp= 660.37 Da 
Ac3-pHis2: MWth= 744.39 Da, MWexp= 744.40 Da.  
 
Potentiometry 
The potentiometric titrations were performed in an air-bath thermostat kept at (25.00 ± 0.05) °C. 
A programmable computer controlled data acquisition unit 3421A, supplied by Hewlett and 
Packard, was used to perform the potentiometric measurements. 
The glass electrodes were Metrohm of 60102-100 type and Ag/AgCl electrode was utilized as 
reference. The EMF values were measured with a precision of ± 0.01 mV using a Keithley 642 type 
Digital Electrometer. 
UV/CD spectra were recorded by model J715 JASCO spectropolarimeter, from 200 to 400 nm 
(optical path 1.00 cm) at 25.0 °C, under a constant flow of nitrogen. 
 
 
 
 
NMR analysis 
All the NMR spectra were recorded at 298 K on a Varian Unity spectrometer operating at a proton 
frequency of 500 MHz, located at the Department of Environmental, Biological and 
Pharmaceutical, Science and Technologies, in Caserta (Italy). 
For the titrations with fac[Re(H2O)3(CO)3]
+ 
or Ga(III) (each used as 8 mM bulk solutions) each 
sample was individually prepared utilizing 4 mM bulk solutions of  pHis2 containing 10% D2O. 1D 
spectra, acquired with 16K and zero-filled to 32 K data points, were obtained for each of the 
following fac[Re(H2O)3(CO)3]
+
/pHis2 molar ratios: 0/1, 0.2/1, 0.5/1, 1/1, 1.5/1. 
The proton chemical shifts were collected at 298 K, at pH = 5.8, and referenced to external TMS (δ 
= 0 ppm). Two-dimensional phase-sensitive TOCSY, NOESY and ROESY spectra 
18
 were 
collected using the States and Haberkorn method. TOCSY, NOESY and ROESY experiments were 
recorded with mixing times of 70, 200 and 150 ms, respectively. Water suppression, when 
necessary, was achieved using the DPFGSE sequence 
19
. Typically, 64 transients of 4K data points 
were collected for each of the 256 increments; the data were zero filled to 1K in ω1. Squared shifted 
sine-bell functions were applied in both dimensions prior to Fourier transformation and baseline 
correction. The data were processed and analyzed using the VNMRJ and CARA software 
20
. 
 
  
Results and Discussion 
Potentiometric studies 
Acidbase behavior of pHis2 chelator 
pHis2 ligand, according to the structure (Fig. 1), has five groups that in acid solution are completely 
protonated giving the H5L
5+
 form.  
 
 
Fig.1. Structure of the bifunctional chelator (pHis2) and related sites of acetylation. 
 
The acidbase equilibria are described by the general equation: 
                     H6pL
(6p)+
 + H2O = H5pL
(5p)+
 + H3O
+ 
        KAp      (1  p  5)                     (1) 
The determination of the protolysis constants is carried out by potentiometric titration at a 
temperature of 25° C in 0.1 M NaClO4 as ionic medium. The solutions analyzed have the following 
composition:  
TS: CL M pHis2, CA M HClO4, CB M NaOH, (0.1 – CA) M NaClO4 
In the test solutions, the concentration of pHis2, ranged from 1.0103 to 4.0103 M, while the 
proton excess, CH = (CACB) is between 2.010
4
 and 7.0103 M. 
The measurement of the hydrogen ion concentration, h = [H3O
+
], is carried out by using the 
following cell: 
                                              GE / TS / RE                                              (A) 
where GE represents the glass electrode, while RE is the reference halfcell: 
RE = 0.1 M NaClO4 / 0.01 M AgClO4, 0.09 M NaClO4 / AgCl(s) / Ag(s) 
The e.m.f. of the cell (A) at a temperature of 25° C results: 
                  EG = EG’ + 0.05916log (hyH) + EJ                            (2) 
where EG’ is a constant in each titration and yH represents the activity coefficient of H
+
 ion, constant 
at a given value of ionic strength (I). The quantity EJ represents the liquid junction potential which 
is generated at the contact between the 0.1 M NaClO4 solution and the measurement solution
21
. This 
quantity depends on the hydrogenionic concentration according to the equation
22
; 
                                 EJ =  0.51h + 0.24Kw/h                                    (3)   
The EG values are recorded when a constant potential value is reached (± 0.0510
3
 V/h). Placing: 
                               EG° = EG’ + 0.05916log (yH)                                (4) 
the equation (2) becomes:   
                          EG = EG° + 0.05916log h + EJ                                  (5)  
Each titration is conducted into two parts: in the first one the constant EG° is determined in a 
solution in the absence of a ligand, reducing the acidity by adding a solution of NaOH of known 
concentration, up to CH = 5.010
5
 M. In the second part, the peptide is added and the alkali solution 
is added, measuring the hydrogen ion concentration. 
From experimental data (CL, CH, [H
+
]) the average number (ZH) of protons released per molecule of 
peptide, is evaluated by: 
ZH = ([H
+
]  CH  Kw/[H
+
])/CL 
where a value  Kw = 10
13.78
 was utilized. Reporting ZH as function of pH (Fig.2) values p from 1 to 
5 are obtained. 
 Fig.2. ZH as function of pH in 0.1 NaClO4 for the H5L
5+
 system. The triangles indicate measurements 
obtained with CL = 2.910
3
 M, while the circles represent return data. The solid line is obtained with 
constant values: log KA1 = 5.35, log KA2 = 7.45, log KA3 = 9.3, log KA4 = 10.3, log KA5 = 10.5. 
 
A speciation model is obtained by processing the experimental data using Hyperquad program
23
. 
In order to attribute the constants to each group, measurements were performed on modified 
peptides, in which some amino groups are acetylated. In particular, we synthesized a mono-
acetylated analog of pHis2 (Ac-pHis2) presenting the acetyl group on the -amino group of Lys2 
and a tri-acetylated analog of pHis2 (Ac3-pHis2) presenting the acetyl groups on the -amino group 
of Lys2, His1 and His5(Fig.1).   
The obtained results are summarized in the Table 1, the species distribution diagram is given in 
Fig.3. 
 
Tab.1. Acid constants of the pHis peptide and its acetylated analogs in 0.1 M NaClO4. 
H6pL
(6p)+
 + H2O = H5pL
(5p)+
 + H3O
+ 
        pKAp  3 
Peptide pKA1 
(His) 
pKA2 
(His) 
pKA3 
(NH2His) 
pKA4 
(NH2His) 
pKA5 
(NH2Lys) 
pHis2 5.35 ± 0.05 7.45 ± 0.05 9.3 ± 0.1 10.3 ± 0.2 10.5 ± 0.3 
AcpHis2 5.40 ± 0.05 7.50 ± 0.05 9.2 ± 0.1 10.4 ± 0.2  
Ac3pHis2 6.25 ± 0.05 8.75 ± 0.05    
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 Fig.3. Acidbase distribution diagram of peptide chelator pHis2 in 0.1 M NaClO4 with CL = 2.010
3
 M  
(1: H5L
5+
; 2: H4L
4+
; 3: H3L
3+
; 4: H2L
2+
; 5: HL
+
; 6: L). 
 
 
Complexation of fac[Re(H2O)3(CO)3]
+
 and Ga
3+
 ions with peptide pHis2 in 0.1 
M NaClO4  
The coordination properties of pHis2 (H5L
5+
) toward fac[Re(H2O)3(CO)3]
+
 and Ga
3+
 (Me
n+
) ions 
can be written in the form: 
               Me
n+
 + q H5L
5+
 = MeH−pLq
(n−p)
 + (5q + p) H
+
   q,−p                (6) 
The measurements are carried out as potentiometric titrations where the hydrogen ion concentration 
is determined by the e.m.f. of cell (A): 
() RE/Test Solution/GE (+)               (A) 
in which GE symbolizes glass electrode and RE is the reference halfcell: 
RE = 0.1 M NaClO4/0.01 M AgClO4, 0.09 M NaClO4/AgCl/Ag 
The test solutions have the general composition: 
TSRe = CMe M MeCl, CL M pHis2, CA M HClO4, CB M NaOH, (0.1  CA) M NaClO4 
 
TSGa = CMe M Me(ClO4)3, CL M pHis2, CA M HClO4, CB M NaOH, (0.1  CA  3CM) M NaClO4 
The concentration of the ligand is varied between 2.0103 M and 8.0103 M, while for both metal 
ions the concentration, CMe, is between 1.010
3
 M and 3.0103 M. 
The proton excess, CH = (CA  CB), varies in the interval 5.010
3
 and 5.0103 M. 
 
fac−[Re(H2O)3(CO)3]
+
)pHis2 system 
In a previous work
17
 the hydrolysis products of Rhenium(I) cation were evaluated. 
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From experimental data (CMe, CL, CH, [H
+
]) obtained in solutions containing different 
fac−[Re(H2O)3(CO)3]
+
) and peptide ratio, the average number of protons ZL released by complexing 
is given that: 
ZL = ([H
+
]  CH  Kw/[H
+
])/CL 
(Kw = 10
13.78
 is water ionic product). Variation of ZH (pH) function is observed (Fig.4) with respect 
free peptide, as a consequence of complexation of the Rhenium(I) cation. 
 
 
Fig.4. ZL as function of pH for the H5L
5+
 system (A) and Re(I)−L system in 0.1 NaClO4 in solutions 
with CMe/CL ratio: 1.0 (diamonds and triangles) (B), 2.0 (squares) (C). The solid lines are obtained with 
the constants reported in Tab.2. 
 
 
Ga
3+pHis2 system 
Potentiometric measurements are carried out both with ligand precursor, such as histidine, and the 
pHis2. For both systems a complexing effect is observed. 
The determination of equilibrium constants is obtained by evaluating ZM: 
ZM = ([H
+
]  CH  Kw/[H
+
])/CMe 
The results are shown in Fig.5 and Fig.6. 
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 Fig.5. ZM as function of pH for Ga(III) hydrolysis system (CMe = 4.810
–3
 M) (A) and Ga(III)−His system 
in 0.1 NaClO4 in solutions with CMe/CL ratio: 1.0 (diamonds), 0.5 (triangles and squares) (B). The solid 
lines are obtained with the constants reported in Tab.2. 
 
 
 
Fig.6. ZM as function of pH for Ga(III) hydrolysis system (CMe = 4.810
–3
 M) (A) and Ga(III)−pHis2 
system in 0.1 NaClO4 in solutions with CMe/CL ratio: 1.0 (diamonds and circles), 2.0 (triangles) (B). The 
solid lines are obtained with the constants reported in Tab.2. 
 
 
Elaboration of data  
The data collected are elaborated with the HYPERQUAD program
23
, where are included the 
Gallium hydrolysis constants, obtained experimentally, and the fac[Re(H2O)3(CO)3]
+
 complex 
reported in the literature
17, 24
.  
In the table are summarized the results obtained: 
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 Tab.2. Equilibrium constants for Ga(III) hydrolysis system and Ga(III)−His, Ga(III)−pHis2 and 
Me
+−pHis2. (Me+: fac–[Re(H2O)3(CO)3]
+
)  
 
Equilibria log(equil. cost.)  3 
Ga
3+
 + 2 H2O = Ga(OH)2
+
 + 2 H
+
 −6.2  0.8 
Ga
3+
 + 3 H2O = Ga(OH)3 + 3 H
+
 –14.1  0.6 
Ga
3+
 + HHis
+
 + 5 H2O = Ga(OH)2His
+
 + 3 H3O
+ 
−6.82  0.09 
Ga
3+
 + H5L
5+ 
+ 6 H2O = Ga(OH)2H3L
4+
 + 4 H3O
+
 −9.69  0.16 
Me
+
 + H5L
5+
 + 2 H2O = MeH3L
4+
 + 2 H3O
+
 
 
−7.07  0.04 
 
To visualize the amounts of the different species, distribution diagram is constructed for 
Rhenium(I)pHis2 system (Fig.7), Gallium(III)His (Fig.8 and Fig.S2) and Gallium(III)pHis2 
(Fig.9 and Fig.S3) .  
For Rhenium(I)pHis2 system, it is observed that the complex Re(CO)3H3L
4+
 reaches a 
concentration greater than 60% in a pH range between 6 and 8. 
 
 
Fig.7. Distribution diagram of fac[Re(H2O)3(CO)3]
+pHis2 system in 0.1 M NaClO4 with CRe(CO)3+ = 
1.0103 M and CL = 2.010
3
 M (1: Re(CO)3
+
; 2: Re(CO)3H3L
4+
, 3: ReH1(CO)3; 4: ReH2(CO)3

). 
 
From the distribution diagram of the Ga (III)His system (ratio 1:1), shown in Fig.8, a prevalence 
of free metal and Ga(OH)2
+
 species is observed up to a pH of around 3, while in the pH range 
between 4 and 6 there is a prevalence of the Ga(OH)2His
+
 complex which reaches a maximum of 
60%. For pH greater than 7, on the other hand,  the Ga(OH)3 hydrolyzed form becomes significant. 
The increase in the CL/CMe ratio, as shown in the diagram in Fig.S2, involves an increase in the 
fraction of the Ga(OH)2His
+
 complex, which reaches a maximum of 80% in the range of pH 46. 
 Fig.8. Distribution diagram of Ga(III)His system in 0.1 M NaClO4 with CMe = CL = 2.010
3
 M (1: 
Ga
3+
; 2: Ga(OH)2
+
, 3: Ga(OH)2His
+
; 4: Ga(OH)3). 
 
The distribution diagrams of the Ga(III)pHis2 system, for different CL/CMe ratios, are shown in 
Fig.9 and Fig.S3. Compared to the Ga(III)His system, a greater pH range (49) is observed in 
which the Ga(OH)2H3L
4+
 complex predominates. For pH greater than 10 it becomes, also in this 
case, the contribution of the Ga(OH)3 species. 
 
Fig.9. Distribution diagram of Ga(III)pHis2 system in 0.1 M NaClO4 with CMe = CL = 2.010
3
 M (1: 
Ga
3+
; 2: Ga(OH)2
+
, 3: Ga(OH)2His
+
; 4: Ga(OH)3). 
 
NMR Results 
The formation of the complexes fac[Re(H2O)3(CO)3]
+
/pHis2 and Ga(III)/pHis2 was followed in a 
short titration where the metal ion was added to a fixed concentration of the peptide chelator. The 
titration was made at pH = 5.8, since the fac[Re(H2O)3(CO)3]
+
 compound was already 
characterized at this pH and its protonation constants are available
17
. For each point of the titration a 
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full set of mono and bidimensional experiments (Fig.S4) was acquired in order to follow the effect 
of the addition on the pHis2.  
The full proton assignment of the pHis2 in H2O at pH = 5.8 is reported in Table S1 of the 
Supplemental Material. Two diagnostic NOE signals allowed the sequential assignment of the 
backbone: NH-Ala3/H-His2, NH-Lys4/H-Ala3. It should be noted that the amine protons of 
His1, Lys2 and His5 are exchangeable in these conditions and thus are not visible in the spectra. 
Furthermore, as the system is highly symmetric only very weak differences are experimented by the 
chemical shifts of the two His and two Lys.  
The formation of the coordination compound with rhenium is shown in Fig. 10, where a comparison 
of the 1D spectra of the free and the fac[Re(H2O)3(CO)3]
+
/pHis2 1.5/1 species demonstrates that 
upon fac[Re(H2O)3(CO)3]
+
 addition the formation of a complex occurs. In fact, the exchangeable 
NH protons of the two histidines become visible at 7.34 ppm in the complex and their peaks integral 
increases with the metal ion/peptide ratio. At the same time, the CH protons of histidines moves 
from 4.07 ppm to 6.12 ppm while the CHfrom 3.22 to 5.81. Interestingly, the imidazole signals of 
both histidines do not experience any change in chemical shifts, thus suggesting that only the 
terminal NHs are involved in the coordination
25, 26
. Accordingly, the potentiometric data indicate, in 
these conditions, the loss of two protons. This unexpected coordination mode has not yet been 
described in literature, whereas imidazole nitrogen has always supposed to be implicated in metal 
coordination
27, 28
. However, it should be noted that in general Tc(I)/Re(I) labeling conditions, unlike 
the conditions used in this work, involves the heating of the labelling mixture. 
A completely different coordination mode is found when the peptide is titrated with Ga(III). Firstly, 
no change in the hydrodynamic properties of the peptide are observed in the DOSY spectra. pHis2 
binds this latter ion by using the histidine side chains. In particular (figure 10), both imidazole 
signals (8.51 and 7.28 ppm) broaden and sensibly change their chemical shift toward higher fields 
upon metal ion addition
29, 30
.  
No multiplication of H2 and H1 signals is observed in the spectra thus indicating the formation of a 
single tautomeric form in solution. The bigger chemical shift change of the H1 suggests that the 
preferred tautomer should be the one with the N protonated and the N involved in the Ga(III) 
coordination
31, 32
. In the Ga(III)-pHis2 spectra, small chemical shift perturbations are observable 
also for the signals belonging to the lysine side chains. The same perturbations are not observable in 
the case of the complex with the fac[Re(H2O)3(CO)3]
+
 thus suggesting a deeper embedment of the 
Ga(III) in the space defined by the two residues lysine sidechains. This behavior can find an 
explanation in the bigger steric hindrance of the fac[Re(H2O)3(CO)3]
+
 complex.  
 
  
 
Fig. 10. 
1
H NMR spectra obtained at different ratio of fac[Re(H2O)3(CO)3]
+
/pHis2 (upper left) and of 
Ga(III)/pHis2 (lower left). Schematic cartoon of fac[Re(H2O)3(CO)3]
+pHis2 (upper right) and 
Ga(III)pHis2 (lower right) complexes (see also Fig.S5). 
 
By potentiometric data, the constants relative to formation of complexes are: 
Me
+
 + H3L
3+
 = MeH3L
4+
        K = 10
12.5
 
and 
Ga(OH)2
+
 + H3L
3+
 = Ga(OH)2H3L
4+
        K = 10
16.1
 
obtained with the constants in Table 2.  
The Ga(III)pHis2 complex has an higher formation constant than Me+−pHis2 one in agreement 
with NMR results. 
 
 
Conclusions 
In the present work, we have spectroscopically analyzed the chemistry in aqueous solution and the 
properties of the histidine-based chelator pHis2 complexed to the fac[Re(H2O)3(CO)3]
+
 and 
Ga(III) to unveil the molecular determinants of their coordination in order to contribute the 
characterization of a novel peptide-based chelating unit that could be exploited for diagnosis and 
therapy. 
Potentiometric and spectroscopic data agree in demonstrating how the peptide behaves in a 
complete different manner in the two cases. In the case of fac[Re(H2O)3(CO)3]
+
 complexation, 
pHis2 uses the up two histidine N-terminal amine groups to coordinate a single metal group 
revealing an unexpected complex structure. In the case of Ga(III), the peptide uses the two histidine 
side chains to bind the metal ion. The metal coordination blocks the two histidines in a preferred 
tautomer with the N protonated and the N involved in the coordination. This different coordination 
mode is due to the bigger steric hindrance of the fac[Re(H2O)3(CO)3]
+
 complex if compared to the 
steric hindrance of the simple Ga(III) metal ion.  
As the selection of proper biomolecular ligands is indispensable in the design of novel 
radiopharmaceutical compounds, our study complements the literature data by describing in details 
the solution equilibria, the coordination properties, the constants of each equilibrium reaction and 
the atomic details of the formed complexes.  
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Supplementary Informations 
Table S1. pHis2 proton chemical shifts (ppm) in H2O at 298 K. 
 NH CH CH Others 
His1 - 4.07 3.22 C2 8.51; C4 7.28 
Lys2 - 3.81 1.72 NHsc 8.14     3.10 
 1.35 1.20 
-Ala3 8.22 2.46 3.40  
Lys4 8.08 4.08 1.61 NHsc 8.14  NH2t  7.52, 7.00 
 3.10   1.35 1.20 
His5 - 4.07 3.22 C2 8.51; C4 7.28 
 
 
 
Figure S1: Analytical characterization by RP-HPLC of pHis2, Ac-pHis2 and Ac3-pHis2 peptides. 
Chromatograms were revealed reading the absorbance at 210 nm. 
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Fig.S2. Distribution diagram of Ga(III)His system in 0.1 M NaClO4 with CMe = 2.010
3
 M and CL = 
4.0103 M (1: Ga3+; 2: Ga(OH)2
+
, 3: Ga(OH)2His
+
; 4: Ga(OH)3). 
 
 
 
Fig.S3. Distribution diagram of Ga(III)pHis2 system in 0.1 M NaClO4 with CMe = 2.010
3
 M and CL = 
4.0103 M (1: Ga3+; 2: Ga(OH)2
+
, 3: Ga(OH)2H3L
+
; 4: Ga(OH)3). 
 
 
 
 
0
50
100
2 4 6 8 10
% 
pH 
1 
2 
3 
4 
0
50
100
2 4 6 8 10 12
1 
2 
3 
4 % 
pH 
  
Fig.S4. 
1
H-
1
H TOCSY and NOESY spectra of the fac[Re(H2O)3(CO)3]
+pHis2 (A and C, respectively) 
and of the Ga(III)pHis2 complexes (B and D). 
 
 
 
 
Fig.S5. Schematic representation of complex formed by pHis2 upon binding with 
fac[Re(H2O)3(CO)3]
+
 (left) and with Ga(III) (right).
    
 
